Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine
- 1 July 1998
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 16 (11-12), 1131-1137
- https://doi.org/10.1016/s0264-410x(98)80110-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Expression of an F1/V fusion protein in attenuatedSalmonella typhimuriumand protection of mice against plagueMicrobial Pathogenesis, 1997
- A new improved sub-unit vaccine for plague: the basis of protectionFEMS Immunology & Medical Microbiology, 1995
- Relationship Between Virulence and Immunity as Revealed in Recent Studies of the Fl Capsule of Yersinia pestisClinical Infectious Diseases, 1995
- Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesisJournal of Medical Microbiology, 1995
- The difference in the IcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strainsMicrobial Pathogenesis, 1992
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences of the United States of America, 1977
- Plague Immunization. V. Indirect Evidence for the Efficacy of Plague VaccineThe Journal of Infectious Diseases, 1974
- Plague Immunization. III. Serologic Response to Multiple Inoculations of VaccineThe Journal of Infectious Diseases, 1974
- Virulence of Pasteurella pestisNature, 1957
- Studies on the Experimental Epidemiology ofRespiratory Infections VIII. Experimental Pneumonic Plague in Macacus RhesusThe Journal of Infectious Diseases, 1957